BiotechTube

Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + Placebo

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Aug 1, 2011 → Sep 1, 2012

NCT ID
NCT01513863

About Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + Placebo

Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + Placebo is a phase 1 stage product being developed by Sun Pharmaceutical for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT01513863. Target conditions include Rosacea.

What happened to similar drugs?

5 of 15 similar drugs in Rosacea were approved

Approved (5) Terminated (2) Active (8)
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
✅Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
✅Azelaic acid 15% + Brimonidine 0.33%BayerApproved
✅Azelaic Acid foam 15%BayerApproved
✅azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
🔄Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01513863Phase 1Completed

Competing Products

20 competing products in Rosacea

See all competitors
ProductCompanyStageHype Score
DFD-04 OintmentDr. Reddy's LaboratoriesPhase 2
32
Minocycline hydrochloride capsulesDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
DFD-29 Extended Release Capsules (40 mg) + DFD-29 Extended Release Capsules (20 mg) + Oraycea® (doxycycline) Capsules + Placebo CapsulesDr. Reddy's LaboratoriesPhase 2
32
DoxycyclineDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
29
lotilaner + VehicleTarsus PharmaceuticalsPhase 2
36
DRM02Eli LillyPhase 2
35
Clascoterone Cream 1%Sun PharmaceuticalPhase 2
42
Azelaic Acid 15% topical gel + Finacea® (azelaic acid) Gel, 15% + PlaceboSun PharmaceuticalPhase 1
29
Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test productSun PharmaceuticalPhase 1
29
Laropiprant + Placebo for LaropiprantMerckPhase 1
29
AMG 334NovartisPhase 2
31
BFH772 1% ointment + Vehicle ointment + Noritate® 1% creamNovartisPhase 2
35
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
27
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
40
Coppertone, BAY1183345BayerPre-clinical
23
Azelaic acid 15% + Brimonidine 0.33%BayerApproved
40
Azelaic Acid foam 15%BayerApproved
40